We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Delivering Portable Chest Radiography Through Glass (TG-CXR) Reduces COVID-19 Infection Risk in Hospitals

By HospiMedica International staff writers
Posted on 20 Apr 2021
Illustration
Illustration
A study to understand the cost and benefit of adopting portable chest radiography through glass (TG-CXR) at a tertiary care centre during the COVID-19 pandemic has found the novel technique to be particularly beneficial.

A team of two technologists at the Department of Radiology, St. Michael's Hospital, University of Toronto (Toronto, ON, Canada) were trained on the TG-CXR method which has the benefit of allowing one technologist to stay outside of the patient room while operating the portable radiography machine, thus reducing PPE use, decreasing the frequency of radiography machine sanitization and reducing their exposure to potentially infectious patients.

The cost of implementing the technique during the current COVID-19 pandemic was obtained from the department's operational database. The direct cost of routinely used PPE and sanitization materials and the cost of the time taken by the technologists to clean the machine was used to form a quantitative picture of the benefit associated with TG-CXR technique.

The technologists were trained on the TG-CXR method during a 15 minute shift change briefing. This translated to a one-time cost of USD 424.88. There was an average reduction of portable radiography machine downtime of four minutes and 48 seconds per study. The benefit of adopting the TG-CXR technique was USD 9.87 per patient imaged, resulting in a projected net cost savings of USD 51,451.84 per annum. Thus, the study concluded that adoption of the TG-CXR technique during the COVID-19 pandemic involves a minimal one-time cost, but can result in a significant benefit over the year.

"We hope that our findings would encourage policy-makers to implement TG-CXR technique at their institutions when and where possible," the study concluded.

Related Links:
University of Toronto

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Ultrasound Needle Guidance System
SonoSite L25

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image:The biotechnology market in the GCC is projected to reach $2.6 billion by 2028, with the UAE and Saudi Arabia leading the growth in the region (Photo Courtesy of Infroma Markets)

WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally

World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more